Carlsmed, Inc.
NMS: CARLLive Quote
About Carlsmed, Inc.
Healthcare
Health Information Services
Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.
📊 Fundamental Analysis
Carlsmed, Inc. demonstrates a profit margin of -58.7%, which is below the sector average, suggesting competitive pressure.
The company recently reported 61.2% revenue growth, which is well above average for the Healthcare sector.
Return on Equity (ROE) is -47.6%, which indicates that capital utilization is currently under pressure.
At a current price of $8.94, CARL currently trades near the bottom of its 52-week range (1%), indicating potential value or weakness (Range: $8.87 - $17.19).
🏥 Financial Health
🔴
Profit Margin
Weak
✅
Debt/Equity
Excellent
✅
Revenue Growth
Excellent
🔴
Return on Equity
Weak
Key Financials
Market Cap
$306.92M
Trailing P/E
--
Forward P/E
-6.02
Beta (5Y)
--
52W High
$17.19
52W Low
$8.87
Avg Volume
124K
Day High
Day Low
📡 Subscribe to ZcoreAI updates
Join the list to get access to:
- Z-Score signals at market open
- New app features and updates
- Exclusive promo for ZcoreAI App